Filing Details

Accession Number:
0001209191-22-030067
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-18 16:39:55
Reporting Period:
2022-05-16
Accepted Time:
2022-05-18 16:39:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649094 Vaxcyte Inc. PCVX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1258693 Grant Pickering C/O Vaxcyte, Inc.
825 Industrial Road, Ste. 300
San Carlos CA 94070
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-16 11,000 $1.79 714,894 No 4 M Direct
Common Stock Disposition 2022-05-16 7,866 $23.76 707,028 No 4 S Direct
Common Stock Disposition 2022-05-16 3,134 $24.28 703,894 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2022-05-16 11,000 $0.00 11,000 $1.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
234,450 2027-05-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 355,660 Indirect By Children's Trusts
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported is a weighted-average price. The shares were sold at prices ranging from $23.17 to $24.16. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The price reported is a weighted-average price. The shares were sold at prices ranging from $24.17 to $24.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The shares subject to the option are fully vested and exercisable.